P G Jenner|M F Brin - JoVE Visualize

Showing results (71-80 of 107) with videos related to

Pageof 11

Sort By:

Cephalalgia : an International Journal of Headache|July 22, 2010

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmM F Brin, S Fahn, C Moskowitz, et al.

Journal of Neurogenetics|May 1, 1986

Linkage analysis in a family with dominantly inherited torsion dystonia: exclusion of the pro-opiomelanocortin and glutamic acid decarboxylase genes and other chromosomal regions using DNA polymorphismsX O Breakefield, S B Bressman, P L Kramer, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2010

An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's diseaseC A Jones, L C Johnston, M J Jackson, et al.

Human Molecular Genetics|November 19, 2004

Transgenic mouse model of early-onset DYT1 dystoniaP Shashidharan, D Sandu, U Potla, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999

Association of a missense change in the D2 dopamine receptor with myoclonus dystoniaC Klein, M F Brin, P Kramer, et al.

Annals of Neurology|November 1, 1994

Dystonia in Ashkenazi Jews: clinical characterization of a founder mutationS B Bressman, D de Leon, P L Kramer, et al.

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|March 11, 2004

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's diseaseC E Morrison, J C Borod, K Perrine, et al.

Annals of Neurology|March 1, 1994

Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studiesD T Dexter, D J Brooks, A E Harding, et al.

Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:

Pageof 11

Cephalalgia : an International Journal of Headache|July 22, 2010

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialS K Aurora, D W Dodick, C C Turkel, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmM F Brin, S Fahn, C Moskowitz, et al.

Journal of Neurogenetics|May 1, 1986

Linkage analysis in a family with dominantly inherited torsion dystonia: exclusion of the pro-opiomelanocortin and glutamic acid decarboxylase genes and other chromosomal regions using DNA polymorphismsX O Breakefield, S B Bressman, P L Kramer, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2010

An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's diseaseC A Jones, L C Johnston, M J Jackson, et al.

Human Molecular Genetics|November 19, 2004

Transgenic mouse model of early-onset DYT1 dystoniaP Shashidharan, D Sandu, U Potla, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 29, 1999

Association of a missense change in the D2 dopamine receptor with myoclonus dystoniaC Klein, M F Brin, P Kramer, et al.

Annals of Neurology|November 1, 1994

Dystonia in Ashkenazi Jews: clinical characterization of a founder mutationS B Bressman, D de Leon, P L Kramer, et al.

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|March 11, 2004

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's diseaseC E Morrison, J C Borod, K Perrine, et al.

Annals of Neurology|March 1, 1994

Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studiesD T Dexter, D J Brooks, A E Harding, et al.

Pageof 11